The sixth mutation was found in one of 768 individuals diagnosed with Behcet disease via targeted sequencing.[1] In vitro studies on functional cellular expression demonstrated that all mutations failed to suppress TNF-induced NF-κB activity, although not in a dominant-negative fashion, which suggested haploinsufficiency as the underlying pathogenic mechanism. This evidence concerns the gene NFKB1 and Behcet disease.